# Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

> **NCT01034969** · — · COMPLETED · sponsor: **Shire** · enrollment: 1761 (actual)

## Conditions studied

- Hereditary Angioedema (HAE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01034969
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-10
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 1761 (ACTUAL)
- **Last updated:** 2024-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034969, "Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01034969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*